NCT02642705

Brief Summary

The present study aims at evaluating the effect of two innovative treatment strategies in obese patients: high intensity interval training and hypoxic conditioning. Obese patients will be randomized in groups performing high intensity interval training, constant load training, hypoxic conditioning or placebo normoxic conditioning for 8 weeks. The effects of the interventions will be measured regarding exercise tolerance, blood pressure, body composition, metabolic status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 30, 2015

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

March 18, 2020

Status Verified

March 1, 2020

Enrollment Period

5.6 years

First QC Date

December 24, 2015

Last Update Submit

March 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maximal exercise capacity

    Maximal oxygen consumption during an incremental exercise test

    8 weeks

Secondary Outcomes (5)

  • Metabolic status

    8 weeks

  • Body composition

    8 weeks

  • Blood pressure

    8 weeks

  • Vascular function

    8 weeks

  • Physical activity

    8 weeks

Study Arms (6)

High intensity interval training N

EXPERIMENTAL

High intensity interval training N: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a high intensity interval training protocol (1 min ON at 100% maximal power output, 1 min OFF), breathing ambient air (normoxia)

Other: High intensity interval training N

High intensity interval training H

EXPERIMENTAL

High intensity interval training H: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a high intensity interval training protocol (1 min ON at 100% maximal power output, 1 min OFF), breathing hypoxic air (about 3 500 m of altitude)

Other: High intensity interval training H

Constant load exercise training N

ACTIVE COMPARATOR

Constant load exercise training N: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a constant load training protocol (50% maximal power output), breathing ambient air (normoxia)

Other: Constant load exercise training N

Constant load exercise training H

EXPERIMENTAL

Constant load exercise training H: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a constant load training protocol (50% maximal power output), breathing hypoxic air (about 3 500 m of altitude)

Other: Constant load exercise training H

Hypoxic conditioning at rest

EXPERIMENTAL

Hypoxic conditioning at rest : The intervention consists in 8-week conditioning period, 3 times a week, hypoxic breathing for one hour (about 4500 m of altitude) while seating quietly

Other: Hypoxic conditioning at rest

Normoxic conditioning at rest

SHAM COMPARATOR

Normoxic conditioning at rest : The intervention consists in 8-week conditioning period, 3 times a week, normoxic breathing for one hour (ambient air) while seating quietly

Other: Normoxic conditioning at rest

Interventions

Exercise training and ambient air breathing

High intensity interval training N

Exercise training and hypoxic breathing

High intensity interval training H

Exercise training and ambient air breathing

Constant load exercise training N

Exercise training and hypoxic breathing

Constant load exercise training H

Hypoxic breathing at rest

Hypoxic conditioning at rest

Normoxic breathing at rest (placebo)

Normoxic conditioning at rest

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI between 27 and 35 kg/m²
  • Physical activity \<2 hours/week
  • No chronic disease or treatment able to interfere with inflammation and metabolic perturbatiosn associated with obesity

You may not qualify if:

  • Diabetes mellitus treated with insulin
  • Auto-immune or inflammatory diseases requiring long term therapy
  • Unstable dysthyroidism
  • Bariatric surgery within the past 18 months
  • Tumoral, inflammatory, infectious, cardiac, respiratory, kidney, digestive disease
  • Untreated sleep apnea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grenoble University Hospital

Grenoble, Auvergne-Rhône-Alpes, 38000, France

RECRUITING

Related Publications (2)

  • Verges S, Chacaroun S, Godin-Ribuot D, Baillieul S. Hypoxic Conditioning as a New Therapeutic Modality. Front Pediatr. 2015 Jun 22;3:58. doi: 10.3389/fped.2015.00058. eCollection 2015.

    PMID: 26157787BACKGROUND
  • Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014 Aug;48(16):1227-34. doi: 10.1136/bjsports-2013-092576. Epub 2013 Oct 21.

    PMID: 24144531BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bernard Wuyam, MD

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Samuel Verges, PhD

CONTACT

Patrice Flore, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 24, 2015

First Posted

December 30, 2015

Study Start

September 1, 2015

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

March 18, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations